ResMed, a medical device company focused on sleep apnea, has launched its first consumer product, a $149 device for tracking and improving sleep called S+. The platform includes a non-contact, ...
Obstructive sleep apnea (OSA) affects almost 1 billion adults worldwide and carries substantial healthcare and productivity costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results